Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update
Go back to Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update| (NASDAQ: ACRS) | Delayed: 4.73 +0.23 (5.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.50 | 52 Week High | $33.88 | |||
| Open | $4.55 | 52 Week Low | $14.12 | |||
| Day High | $4.78 | P/E | N/A | |||
| Day Low | $4.50 | EPS | $0.00 | |||
| Volume | 443,895 | |||||
